Advil Multi-Symptom Cold and Flu is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Chlorpheniramine Maleate; Ibuprofen; Phenylephrine Hydrochloride.
| Product ID | 0573-0190_2b02a49b-750d-4ea3-b51f-8e799c09bcd0 |
| NDC | 0573-0190 |
| Product Type | Human Otc Drug |
| Proprietary Name | Advil Multi-Symptom Cold and Flu |
| Generic Name | Chlorpheniramine Maleate, Ibuprofen, Phenylephrine Hcl |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-06-25 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022113 |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Substance Name | CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE |
| Active Ingredient Strength | 4 mg/1; mg/1; mg/1 |
| Pharm Classes | Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-1 Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2018-06-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022113 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-11-01 |
| Marketing Category | NDA |
| Application Number | NDA022113 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-06-25 |
| Marketing Category | NDA |
| Application Number | NDA022113 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-06-25 |
| Marketing Category | NDA |
| Application Number | NDA022113 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-06-25 |
| Marketing Category | NDA |
| Application Number | NDA022113 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-06-25 |
| Marketing Category | NDA |
| Application Number | NDA022113 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-06-25 |
| Ingredient | Strength |
|---|---|
| CHLORPHENIRAMINE MALEATE | 4 mg/1 |
| SPL SET ID: | 7671d104-3c5c-4f63-b6b1-6c91c22592f8 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |